lofexidine

This page covers all lofexidine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-2A adrenergic receptor.

Targets

Alpha-2A adrenergic receptor

Marketed (1)

• Lucemyra · Biocorrx Pharms · Neuroscience
  Lucemyra works by activating the alpha-2A adrenergic receptor to reduce the release of norepinephrine, a neurotransmitter involved in withdrawal symptoms.